IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced imm... IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. Show more
-- Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma of the Head and Neck Cohort -- -- No New Safety...
- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that the trial continue without modifications- No new safety...
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its...
Phase 3 interim analysis outcome still expected in Q3 2024 for the overall response rate (ORR) in the pivotal trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine...
NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -9.40170940171 | 1.17 | 1.24 | 0.98 | 293775 | 1.09509501 | CS |
4 | -0.46 | -30.2631578947 | 1.52 | 1.557 | 0.7327 | 1109989 | 1.01089302 | CS |
12 | -0.16 | -13.1147540984 | 1.22 | 1.73 | 0.7327 | 466368 | 1.11753711 | CS |
26 | -0.68 | -39.0804597701 | 1.74 | 1.8 | 0.7327 | 273478 | 1.17217406 | CS |
52 | -0.19 | -15.2 | 1.25 | 2.098 | 0.7327 | 205001 | 1.26628799 | CS |
156 | -14.94 | -93.375 | 16 | 17.88 | 0.7327 | 129554 | 2.67599578 | CS |
260 | -14.94 | -93.375 | 16 | 17.88 | 0.7327 | 129554 | 2.67599578 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.